We found that HCP5 overexpression increased the risk of shorter overall survival in most cancers (non-small cell lung cancer, colorectal cancer, oral squamous cell carcinoma, clear cell renal cell carcinoma, gastric cancer and osteosarcoma). This evidence concerns the gene HCP5 and non-small cell lung carcinoma.